Source - SMW
Cancer treatment monitoring provider Physiomics said it had been awarded a £35k contract by a new major pharmaceutical client.

The project, expected to be completed during the company's current financial year, involved the use of Physiomics' Virtual Tumour technology.




Related Charts

Physiomics (PYC)

-0.10p (-1.67%)
delayed 16:57PM